Indicated for: cancer
Route of administration: injectable
Substance: sulesomab (monoclonal antibody)
ATC: V09HA04 (Various | Inflammation and infection detection | Technetium (99mtc) compounds)
Sulesomab is a radiolabeled monoclonal antibody used in medical imaging for the diagnosis of bone infections and other inflammations. It binds to receptors on the surface of leukocytes, allowing the localization of infection or inflammation sites through scanning.
The medication is administered intravenously, as directed by a doctor, prior to the scan. It is important for patients to be monitored to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions and fever. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before the procedure.